Analysts Anticipate Agilent Technologies Inc (NYSE:A) Will Announce Quarterly Sales of $1.24 Billion

Wall Street brokerages forecast that Agilent Technologies Inc (NYSE:A) will report $1.24 billion in sales for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for Agilent Technologies’ earnings. The highest sales estimate is $1.25 billion and the lowest is $1.23 billion. Agilent Technologies reported sales of $1.20 billion in the same quarter last year, which indicates a positive year over year growth rate of 3.3%. The business is scheduled to report its next quarterly earnings report on Tuesday, August 13th.

On average, analysts expect that Agilent Technologies will report full-year sales of $5.10 billion for the current year, with estimates ranging from $5.09 billion to $5.11 billion. For the next financial year, analysts anticipate that the firm will report sales of $5.43 billion, with estimates ranging from $5.37 billion to $5.49 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover Agilent Technologies.

Agilent Technologies (NYSE:A) last announced its earnings results on Tuesday, May 14th. The medical research company reported $0.71 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.72 by ($0.01). Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The firm had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the previous year, the firm earned $0.65 EPS. Agilent Technologies’s revenue for the quarter was up 2.7% on a year-over-year basis.

Several equities research analysts recently commented on the company. Wolfe Research began coverage on Waters in a report on Thursday, May 30th. They set an “underperform” rating on the stock. Cowen upped their price target on Agilent Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a report on Tuesday, March 26th. Deutsche Bank upped their price target on Alphabet from $1,300.00 to $1,400.00 and gave the company a “buy” rating in a report on Wednesday, May 15th. ValuEngine raised Valmont Industries from a “sell” rating to a “hold” rating in a report on Friday, July 12th. Finally, Piper Jaffray Companies set a $29.00 price target on Bausch Health Companies and gave the company a “buy” rating in a report on Tuesday, June 11th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company. Agilent Technologies presently has a consensus rating of “Buy” and a consensus target price of $83.92.

Large investors have recently made changes to their positions in the business. Captrust Financial Advisors raised its stake in Agilent Technologies by 2,121.1% in the 4th quarter. Captrust Financial Advisors now owns 422 shares of the medical research company’s stock worth $29,000 after purchasing an additional 403 shares in the last quarter. Lake Point Wealth Management bought a new stake in Agilent Technologies during the fourth quarter valued at about $30,000. Destination Wealth Management boosted its holdings in Agilent Technologies by 100.0% during the first quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock valued at $32,000 after acquiring an additional 200 shares during the period. Financial Gravity Wealth Inc. acquired a new position in shares of Agilent Technologies during the first quarter valued at about $52,000. Finally, NEXT Financial Group Inc raised its position in Agilent Technologies by 22.0% in the second quarter. NEXT Financial Group Inc now owns 925 shares of the medical research company’s stock worth $69,000 after purchasing an additional 167 shares in the last quarter.

NYSE:A traded up $0.54 during midday trading on Friday, hitting $70.13. 2,169,374 shares of the stock were exchanged, compared to its average volume of 2,245,426. Agilent Technologies has a one year low of $61.01 and a one year high of $82.27. The company has a market cap of $21.99 billion, a P/E ratio of 25.14, a price-to-earnings-growth ratio of 1.95 and a beta of 1.41. The company’s 50-day moving average price is $71.62. The company has a debt-to-equity ratio of 0.35, a current ratio of 3.41 and a quick ratio of 2.82.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be paid a dividend of $0.164 per share. This represents a $0.66 annualized dividend and a yield of 0.94%. The ex-dividend date is Monday, July 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.66%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Read More: Municipal Bonds

Get a free copy of the Zacks research report on Agilent Technologies (A)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.